NHS treatments blacklist

NHS Treatments Blacklist is a list of treatments and procedures that the National Health Service (NHS) in the United Kingdom has deemed to be of low or no clinical value. The list is intended to guide healthcare providers in their decision-making process and to ensure that NHS resources are used efficiently and effectively.

Overview

The NHS Treatments Blacklist, also known as the Low Value Treatments list, was first introduced in 2006. It is regularly updated by the NHS England and the National Institute for Health and Care Excellence (NICE), based on the latest clinical evidence and research. The list includes treatments and procedures that are considered to be ineffective, unnecessary, or inappropriate for certain conditions or patient groups.

Criteria for Inclusion

The criteria for inclusion on the NHS Treatments Blacklist are based on a rigorous evaluation process. This process includes a review of the latest clinical evidence, consultation with healthcare professionals and patient groups, and consideration of the cost-effectiveness of the treatment or procedure. Treatments and procedures may be included on the list if they are deemed to be:

• Of low clinical effectiveness
• Cost-ineffective
• Inappropriate for routine use in the NHS
• Better managed in other ways, such as through lifestyle changes or self-care

Impact on Patient Care

The NHS Treatments Blacklist has a significant impact on patient care within the NHS. Healthcare providers are discouraged from offering treatments and procedures on the list, and patients may be denied access to these treatments on the NHS. However, exceptions can be made in certain circumstances, such as when a patient's individual clinical needs justify the use of a blacklisted treatment.

Controversies and Criticisms

The NHS Treatments Blacklist has been the subject of controversy and criticism. Some healthcare professionals and patient groups argue that the list restricts patient choice and undermines the principle of individualised care. There are also concerns that the list may be used to ration care and reduce spending in the NHS, rather than to improve the quality and effectiveness of care.

See Also

• National Health Service
• National Institute for Health and Care Excellence
• Healthcare in the United Kingdom
• Healthcare rationing in the United Kingdom

External Links

This article is a stub related to pharmacology. You can help WikiMD by expanding it!